February 10, 2021
“By the end of March, we’re likely going to have more than 200 million doses of the vaccines available,” explains Raymond James Healthcare Policy Analyst Chris Meekins.
Recorded February 1, 2021
Markets & Investing September 27, 2023 Raymond James CIO Larry Adam discusses why we were due for the...
Economy & Policy September 26, 2023 Raymond James Senior Investment Strategist Tracey Manzi discusses...
Technology & Innovation A pandemic necessity. But, how have remote preferences and hybrid workstyles...